Inhibitor Therapeutics, Inc. Share-based Payment Arrangement, Expense
Inhibitor Therapeutics, Inc. (INTI) reported Share-based Payment Arrangement, Expense of $333.88 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-10-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2014-10-10
- Inhibitor Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2014-09-30 was $333.88K.
- Inhibitor Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2014-06-30 was $0.00.
- Inhibitor Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2014-03-31 was $0.00.
- Inhibitor Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2013-12-31 was $0.00.
- Inhibitor Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2013 was $0.00.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $333.88K 10-Q · filed 2014-10-10 | $333.88K derived: sum of 2 quarters · filed 2014-10-10 | $333.88K 10-Q · filed 2014-10-10 | $333.88K derived: sum of 4 quarters · filed 2014-10-10 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $0.00 10-Q · filed 2014-08-13 | $0.00 derived: sum of 3 quarters · filed 2014-08-13 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2014-05-12 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-15 | $0.00 10-K · filed 2014-04-15 | ||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-14 |